These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18463152)

  • 1. A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters.
    Lamirande EW; DeDiego ML; Roberts A; Jackson JP; Alvarez E; Sheahan T; Shieh WJ; Zaki SR; Baric R; Enjuanes L; Subbarao K
    J Virol; 2008 Aug; 82(15):7721-4. PubMed ID: 18463152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.
    Fett C; DeDiego ML; Regla-Nava JA; Enjuanes L; Perlman S
    J Virol; 2013 Jun; 87(12):6551-9. PubMed ID: 23576515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
    Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
    J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.
    Buchholz UJ; Bukreyev A; Yang L; Lamirande EW; Murphy BR; Subbarao K; Collins PL
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9804-9. PubMed ID: 15210961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine.
    Roberts A; Lamirande EW; Vogel L; Baras B; Goossens G; Knott I; Chen J; Ward JM; Vassilev V; Subbarao K
    Viral Immunol; 2010 Oct; 23(5):509-19. PubMed ID: 20883165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.
    Netland J; DeDiego ML; Zhao J; Fett C; Álvarez E; Nieto-Torres JL; Enjuanes L; Perlman S
    Virology; 2010 Mar; 399(1):120-128. PubMed ID: 20110095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
    Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
    Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission.
    Ye C; Park JG; Chiem K; Dravid P; Allué-Guardia A; Garcia-Vilanova A; Pino Tamayo P; Shivanna V; Kapoor A; Walter MR; Kobie JJ; Plemper RK; Torrelles JB; Martinez-Sobrido L
    Microbiol Spectr; 2023 Jun; 11(3):e0065323. PubMed ID: 37191507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo.
    DeDiego ML; Alvarez E; Almazán F; Rejas MT; Lamirande E; Roberts A; Shieh WJ; Zaki SR; Subbarao K; Enjuanes L
    J Virol; 2007 Feb; 81(4):1701-13. PubMed ID: 17108030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines.
    See RH; Petric M; Lawrence DJ; Mok CPY; Rowe T; Zitzow LA; Karunakaran KP; Voss TG; Brunham RC; Gauldie J; Finlay BB; Roper RL
    J Gen Virol; 2008 Sep; 89(Pt 9):2136-2146. PubMed ID: 18753223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.
    He Y; Zhu Q; Liu S; Zhou Y; Yang B; Li J; Jiang S
    Virology; 2005 Mar; 334(1):74-82. PubMed ID: 15749124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters.
    Roberts A; Thomas WD; Guarner J; Lamirande EW; Babcock GJ; Greenough TC; Vogel L; Hayes N; Sullivan JL; Zaki S; Subbarao K; Ambrosino DM
    J Infect Dis; 2006 Mar; 193(5):685-92. PubMed ID: 16453264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
    See RH; Zakhartchouk AN; Petric M; Lawrence DJ; Mok CPY; Hogan RJ; Rowe T; Zitzow LA; Karunakaran KP; Hitt MM; Graham FL; Prevec L; Mahony JB; Sharon C; Auperin TC; Rini JM; Tingle AJ; Scheifele DW; Skowronski DM; Patrick DM; Voss TG; Babiuk LA; Gauldie J; Roper RL; Brunham RC; Finlay BB
    J Gen Virol; 2006 Mar; 87(Pt 3):641-650. PubMed ID: 16476986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis.
    DeDiego ML; Nieto-Torres JL; Jiménez-Guardeño JM; Regla-Nava JA; Alvarez E; Oliveros JC; Zhao J; Fett C; Perlman S; Enjuanes L
    PLoS Pathog; 2011 Oct; 7(10):e1002315. PubMed ID: 22028656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters.
    Roberts A; Vogel L; Guarner J; Hayes N; Murphy B; Zaki S; Subbarao K
    J Virol; 2005 Jan; 79(1):503-11. PubMed ID: 15596843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity.
    Du L; Zhao G; Chan CC; Sun S; Chen M; Liu Z; Guo H; He Y; Zhou Y; Zheng BJ; Jiang S
    Virology; 2009 Oct; 393(1):144-50. PubMed ID: 19683779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.
    Bolles M; Deming D; Long K; Agnihothram S; Whitmore A; Ferris M; Funkhouser W; Gralinski L; Totura A; Heise M; Baric RS
    J Virol; 2011 Dec; 85(23):12201-15. PubMed ID: 21937658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
    Sheahan T; Whitmore A; Long K; Ferris M; Rockx B; Funkhouser W; Donaldson E; Gralinski L; Collier M; Heise M; Davis N; Johnston R; Baric RS
    J Virol; 2011 Jan; 85(1):217-30. PubMed ID: 20980507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
    Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N
    J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.
    Callendret B; Lorin V; Charneau P; Marianneau P; Contamin H; Betton JM; van der Werf S; Escriou N
    Virology; 2007 Jul; 363(2):288-302. PubMed ID: 17331558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.